PROTACs: Mechanism and Bioavailability enhancement strategies by nanotechnology, RNA viral infections (vaccine strategy) and Prodrug development

Proteolysis Targeting Chimera (PROTACs) are a brand-new concept of therapeutics that use the ubiquitin-proteasome system for selective degradation of disease-related proteins. Like other therapeutics, PROTACs function by recruiting a protein target and a ubiquitin ligase that leads to the degradati...

Description complète

Détails bibliographiques

Auteurs principaux:	Sanaul Mustafa, Md Sabir Hussain Siddiquee
Format:	Artigo
Langue:	Inglês
Publié:	German Journal of Pharmaceuticals and Biomaterials 2025-01-01
Collection:	German Journal of Pharmaceuticals and Biomaterials
Sujets:	PROTAC targeted protein degradation RNA viral infections prodrug Oncology Alzheimer’s disease
Accès en ligne:	https://gjpb.de/index.php/gjpb/article/view/154
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!